Sagamihara, Japan

Tomokazu Hosokawa


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 20(Granted Patents)


Company Filing History:

goldMedal1 out of 832,912 
Other
 patents

Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Tomokazu Hosokawa in Eye Disease Treatment

Introduction

Tomokazu Hosokawa is a notable inventor based in Sagamihara, Japan. He has made significant contributions to the field of medicinal compositions, particularly in the treatment of eye diseases. His innovative work focuses on developing effective remedies for conditions that involve increased ocular tension.

Latest Patents

Hosokawa holds a patent for medicinal compositions aimed at treating eye diseases. This patent features 2-alkynyladenosine derivatives, which contain an acetylene union at the 2-position of the adenine base. These compositions are recognized for their long-lasting and remarkable effects in lowering ocular tension. They are particularly useful for treating eye diseases associated with increased ocular tension or optic nerve failures, such as glaucoma and hypertonia oculi.

Career Highlights

Throughout his career, Hosokawa has demonstrated a commitment to advancing medical science through his innovative research. His work has not only contributed to the understanding of eye diseases but has also provided practical solutions for patients suffering from these conditions.

Collaborations

Hosokawa has collaborated with notable colleagues, including Kazuki Endo and Toichi Abiru. These partnerships have enhanced the research and development of his medicinal compositions, leading to more effective treatments for eye diseases.

Conclusion

Tomokazu Hosokawa's contributions to the field of eye disease treatment through his innovative patents highlight the importance of research and collaboration in medical advancements. His work continues to impact the lives of those affected by ocular conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…